Hi, have you seen the maker's site showing statistics from the trial that got it approved for CLL?
https://www.imbruvica.com/hcp/cll/efficacy/orr.php
Are you familiar with how to interpret the stats? The ORR is 42.6%
Far better than the ofatumumab, it seems.
Thank you. It seems to be doing quite well for me. The only side effect, that is bothersome, is dizziness if trying to do anything that requires a little bit of exertion. Doc says it is from my anemia. So, at 79, I just take it easy.
I'm not sure what stats you are referring to. And can you tell me what is ORR 42.6%? Thank You again.